Disclaimer: We may earn a commission if you make any purchase by clicking our links. Please see our detailed guide here.

Follow us on:

Minimal Diversity of Coronavirus Suggests the Global Vaccine is Feasible

Join the Opinion Leaders Network

Join the Techgenyz Opinion Leaders Network today and become part of a vibrant community of change-makers. Together, we can create a brighter future by shaping opinions, driving conversations, and transforming ideas into reality.

Scientists have assessed the genome sequences of the novel coronavirus from more than 27,000 individuals with COVID-19 and found that the virus has mutated minimally since the beginning of the outbreak in China in December 2019, suggesting one vaccine would be sufficient to combat global infections.

The study, published in the journal PNAS, characterized the diversification of the novel coronavirus SARS-CoV-2 since the beginning of the pandemic by aligning 18,514 independent virus genome sequences sampled from individuals in 84 countries and scanning them for variations.

According to the scientists, including those from the Walter Reed Army Institute of Research (WRAIR) in the US, the analyses reveal low estimates of genetic differentiation of the virus following the initial outbreak in Wuhan, China.

Based on the study, they said, so far, the SARS-CoV-2 genome has evolved through a mostly random process rather than through adaptation to the human hosts it encounters.

Earlier studies had pointed to the domination of a mutant form of the virus in several parts of the world in which a molecule of aspartic acid — denoted as D — in the viral spike protein, which it uses to enter host cells, is replaced by another molecule glycine (G).

However, the scientists behind the current study said this ‘D614G’ mutation cannot be seen as evidence of the virus adapting to humans.

Like other reports, we noticed that the D614G mutation in the Spike has rapidly increased in frequency since the beginning of the epidemic, but we could not link this mutation to specific adaptive forces.- Morgane Rolland, a co-author of the study from WRAIR.

“When viruses replicate and spread in the population, we expect to see some mutations and some can become fixed very rapidly in an epidemic just by random chance,” Rolland added.

The scientists said linking genotypes of the different strains to their traits is complicated, adding that more research is needed to fully understand the functional consequences of the D614G mutation in SARS-CoV-2.

Given the low level of genetic variation, the researchers said, a promising vaccine candidate would likely be equally efficacious against all currently circulating strains of the novel coronavirus.

“Viral diversity has challenged vaccine development efforts for other viruses such as HIV, influenza, and dengue, but global samples show SARS-CoV-2 to be less diverse than these viruses,” Rolland said.

“We can therefore be cautiously optimistic that viral diversity should not be an obstacle for the development of a broadly protective vaccine against COVID-19 infection,” she added.

The researchers believe the current findings may lead to the development of a vaccine that is rapidly scalable and universally applicable to all populations.

Partner With Us

Digital advertising offers a way for your business to reach out and make much-needed connections with your audience in a meaningful way. Advertising on Techgenyz will help you build brand awareness, increase website traffic, generate qualified leads, and grow your business.

Join 10,000+ Fellow Readers

Get Techgenyz’s roundup delivered to your inbox curated with the most important for you that keeps you updated about the future tech, mobile, space, gaming, business and more.


Find Apps

The Ultimate Hub for Discovering Apps Unlock a world of apps: your ultimate hub for exploring and discovering limitless possibilities for on your every needs.

Power Your Business

Solutions you need to super charge your business and drive growth

More from this topic